Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 – University of Cologne – Webdesign by Effect Group Ltd.

4th Aniridia webcast webinar: A fresh look to aniridia pathophysiology with a focus on translational implications by juan A. de Toledo & Paolo Rama.

Aniridia-Net and Aniridia Europe are happy to announce this new webinar on aniridia, recommended to an audience of professionals working in the field.

The speakers, Dr. Juan Álvarez de Toledo (Centro de Oftalmología Barraquer, Barcelona, Spain) and Dr. Paolo Rama (Ospedale San Raffaele, Milan, Italy) have been working since many years with aniridic patients and have a relevant expertise in the field. They belong to Aniridia Europe’s Scientific committee. Introduced by Dr. Giulio Ferrari (Ospedale San Raffaele, Milan, Italy, and a member of the Aniridia-Net Management Committee) they will address the following questions:
What is emerging as the most relevant pathologic alteration in aniridia eyes?
What can this teach us about inflammation and its management in this patients?
Any news on the management of fibrosis in these patients?
The role of stem cell deficiency and inflammation: what comes first?
What should be expected to be the visual prognosis today?
Could you draw an updated algorithm on how these patients should be followed up today, clinically and surgically?

The link to follow the webinar will be published close to the event in Aniridia Europe website ( No registration is needed. The webinar will last approximately 40 minutes.

Friday 22th October 2021 at 18:00 CEST, live streamed in Aniridia Europe’s YouTube Channel

Save the date for this meeting with science and aniridia!

* Recommended audience: professionals working in the field.

No Comments

Post A Comment